S81557 |
PFI-4 |
源叶(MedMol) | 98% |
- 提示:详情请下载说明书。
- 产品描述: PFI-4 (compound 11) is a potent and highly selective BRPF1 Bromodomain (BRPF1B) inhibitor, with an IC50 of 172 nM. PFI-4 can be used to explore the functional mechanisms of the HBO1/BRPF1 complex and to study bone loss and osteolytic malignant bone lesions
- 靶点: IC50: 3.517 μM (BRPF2), >10 μM (BRD4 (1)), 0.172 μM (BRPF1B), >10 μM (TRIM24);EpigeneticReaderDomain
- 体外研究:
PFI-4 (1.25 µM; 7 or 11 days) inhibits differentiation of human osteoclasts. Cell Viability Assay Cell Line: Osteoclasts Concentration: 1.25 µM Incubation Time: 7 or 11 days Result: Significantly reduces MMP9 secretion in osteoclasts.
- 参考文献:
1. Meier JC, et al. Selective Targeting of Bromodomains of the Bromodomain-PHD Fingers Family Impairs Osteoclast Differentiation. ACS Chem Biol. 2017 Oct 20;12(10):2619-2630. 2. Demont EH, et al. 1,3-Dimethyl Benzimidazolones Are Potent, Selective Inhibitors of the BRPF1 Bromodomain. (2014) ACS Med Chem Lett. 5(11):1190-1195.
- 溶解性: soluble in DMSO
- 保存条件: -20℃
- 配置溶液浓度参考:
1mg 5mg 10mg 1 mM 2.629 ml 13.143 ml 26.285 ml 5 mM 0.526 ml 2.629 ml 5.257 ml 10 mM 0.263 ml 1.314 ml 2.629 ml 50 mM 0.053 ml 0.263 ml 0.526 ml
- 注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。
输入产品批号:
本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)